FSMDX
Price
$33.25
Change
+$0.44 (+1.34%)
Updated
May 8 closing price
Net Assets
37.69B
GVCAX
Price
$10.39
Change
+$0.01 (+0.10%)
Updated
May 8 closing price
Net Assets
207.03M
Ad is loading...

FSMDX vs GVCAX

Header iconFSMDX vs GVCAX Comparison
Open Charts FSMDX vs GVCAXBanner chart's image
Fidelity Mid Cap Index
Price$33.25
Change+$0.44 (+1.34%)
VolumeN/A
Net Assets37.69B
Gabelli Value 25 AAA
Price$10.39
Change+$0.01 (+0.10%)
VolumeN/A
Net Assets207.03M
FSMDX vs GVCAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSMDX vs. GVCAX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMDX is a Buy and GVCAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FSMDX has more cash in the bank: 37.7B vs. GVCAX (207M). FSMDX pays higher dividends than GVCAX: FSMDX (1.21) vs GVCAX (0.53). FSMDX was incepted earlier than GVCAX: FSMDX (14 years) vs GVCAX (15 years). GVCAX (1.49) is less costly to investors than FSMDX (0.03). FSMDX is a more actively managed with annual turnover of: 8.00 vs. GVCAX (5.00). FSMDX has a lower initial minimum investment than GVCAX: FSMDX (0) vs GVCAX (1000). FSMDX (5.24) and GVCAX (5.11) have marching annual gain over last year. FSMDX return over 5 years is better than : 75.46 vs. GVCAX (-4.06).
FSMDXGVCAXFSMDX / GVCAX
Total Expense Ratio0.031.492%
Annual Report Gross Expense Ratio0.031.492%
Fund Existence14 years15 years-
Gain YTD-2.8435.274-54%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets37.7B207M18,213%
Annual Yield % from dividends1.210.53226%
Returns for 1 year5.245.11103%
Returns for 3 years29.17-11.22-260%
Returns for 5 years75.46-4.06-1,858%
Returns for 10 years98.68-42.39-233%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BBDO2.400.30
+14.29%
Banco Bradesco SA
GLUE4.220.37
+9.61%
Monte Rosa Therapeutics
GRC37.751.07
+2.92%
Gorman-Rupp Company (The)
SNDR23.030.63
+2.81%
Schneider National
KALA3.43-0.02
-0.58%
Kala BIO